Lesson plan

Humax

HuMax is an abbreviation for "human monoclonal antibody targeting", used by the pharmaceutical company Genmab in trade names. Examples include: * HuMax-CD4 (zanolimumab) * HuMax-CD20 (ofatumumab) * HuMax-EGFr (zalutumumab)

Back to article

Article summary

HuMax is an abbreviation for "human monoclonal antibody targeting", used by the pharmaceutical company Genmab in trade names. Examples include: * HuMax-CD4 (zanolimumab) * HuMax-CD20 (ofatumumab) * HuMax-EGFr (zalutumumab)

Key claims

  1. date of foundation: 1989 — source: Wikipedia, revision 1362008710, retrieved 2026-10-20 · confidence 0.95

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. The record states that the date of foundation is "1989". What evidence would count against this claim?
  3. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  4. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

  1. Wikipedia, “Humax”, revision 1362008710, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1362008710

Key claims and bibliography are generated from the same tracked claims and sources as the article page.